Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2020

May 5, 2020

284_dirs_2020-05-05_4d94c149-81d6-43c8-adea-3bc07ba15ac8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2020-05-01

Reporting Person: Fleming Michael (SVP Chief Ethics & Com Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-05-03 Common Stock M 1541 $77.67 Acquired 6089.334 Direct
2020-05-03 Common Stock F 529 $77.67 Disposed 5560.334 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-05-01 Stock Option (Right to Buy) $77.67 A 21144 Acquired 2030-04-30 Common Stock (21144) Direct
2020-05-01 Restricted Stock Unit $ A 2704 Acquired 2023-05-01 Common Stock (2704) Direct
2020-05-03 Restricted Stock Unit $ M 1541 Disposed 2022-05-03 Common Stock (1541) Direct

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: The option vests and becomes exercisable in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.

F3: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F4: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.

F5: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.